That was definitely said at the AGM due to the voucher only being available if the HLHS indication was approved before CHF. I would assume that the CHF will take much more work to approve than the HLHS as it is so small an indication and it is an orphan disease. Maybe they know that it will be faster to get it done and CHF. Just guesses on my behalf though.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)